NIO Inc. vs Nike, Inc. — Stock Comparison
Q·Score Breakdown
4.6
Bearish
Overall
6.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
NIO
Revenue expanding at 76% year-over-year.
⚠ currently unprofitable (-18% margin).
NKE
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 35% year-over-year.
Analyst Consensus
BUY
Target $6.67 (+12.9%)
23 analysts
HOLD
Target $61.68 (+38.9%)
33 analysts
Fundamentals
NIO
NKE
—
Trailing P/E
29.2×
-298.5×
Forward P/E
24.1×
-17.8%
Profit Margin
4.8%
13.6%
Gross Margin
40.9%
-118.7%
ROE
16.0%
75.9%
Revenue Growth
0.1%
—
Earnings Growth
-34.8%
0.99
Beta
1.32
—
Price / Book
—
$14.8B
Market Cap
$65.8B
$3 – $8
52-Week Range
$42 – $80
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →